Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Ann Hematol ; 100(9): 2375-2380, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34180023

ABSTRACT

Damage to gut mucosa following conditioning regimens may favour bacterial infections that can trigger graft versus host disease (GvHD) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Rifaximin, an oral and non-absorbable antibiotic, has been recently proposed as effective prophylaxis to reduce bacterial infections in the gut and consequently acute GvHD in this setting. The present study evaluated safety and outcomes of HSCT patients that were treated with rifaximin prophylaxis at Perugia University Hospital. Rifaximin prophylaxis was introduced as standard of care in HSCT patients in May 2018. We retrieved data from 118 consecutive transplants, and we compared the outcomes of rifaximin-treated patients with historical controls that did not receive antibiotic prophylaxis. While incidences of neutropenic fever, documented bacterial infections, and aGvHD were similar in the two groups, we found an increased frequency of invasive candidiasis and clinically relevant Candida spp. infections in rifaximin-treated patients (5 patients vs 1 patient, 25% [± 0.99%] vs 1% [± 0.01%], p < .0001). Three rifaximin-treated patients experienced life-threating candidemia (2 C. krusei, 1 C. orthopsilosis). Rifaximin was the only factor that increased the risk of Candida spp. infections. Rifaximin could have contributed to microbiome disruption which favoured an outbreak of life-threatening Candida infections. This important complication forced us to halt its use. Larger, prospective studies are needed to assess the impact of rifaximin prophylaxis on incidence of bacterial infections, aGvHD, and survival of HSCT patients.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Candida/drug effects , Candidiasis/drug therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Micafungin/therapeutic use , Rifaximin/therapeutic use , Anti-Bacterial Agents/adverse effects , Drug Resistance, Fungal , Female , Humans , Male , Middle Aged , Retrospective Studies , Rifaximin/adverse effects , Risk Factors , Transplantation, Homologous/adverse effects
2.
Case Rep Infect Dis ; 2019: 7403878, 2019.
Article in English | MEDLINE | ID: mdl-31827952

ABSTRACT

Histoplasma capsulatum is a dimorphic fungus, endemic in the Americas, Africa (var. duboisii), India, and Southeast Asia. H. capsulatum infection is rarely diagnosed in Italy, while in Latin America, progressive disseminated histoplasmosis (PDH) is one of the most frequent AIDS-defining illnesses and causes of AIDS-related deaths. We report a case of PDH and new HIV infection diagnosis in a Cuban patient, who has been living in Italy for the past 10 years. Bone marrow aspirate and peripheral blood smear microscopy suggested H. capsulatum infection. The diagnosis was confirmed with the culture method identifying its thermal dimorphism. Liposomal amphotericin B was administered alone for 10 days and then for another 2 days, accompanied with voriconazole; the former was stopped for probable side effects (persistent fever and worsening thrombocytopenia), and voriconazole was continued to complete 4 weeks. PDH maintenance treatment consisted of itraconazole for one year. Antiretroviral therapy (ART) was started on the third week of antifungal treatment. At the 3-year follow-up, the patient is adherent on ART, the virus was suppressed, and she has an optimal immune recovery. This case highlights the need to suspect histoplasmosis in the differential diagnosis of opportunistic infections in immunocompromised persons, native to or who have traveled to endemic countries.

3.
Top Curr Chem (Cham) ; 374(1): 5, 2016 Feb.
Article in English | MEDLINE | ID: mdl-27572988

ABSTRACT

Despite the large diffusion of natural organic substances in art-historical materials, their characterization presents many challenges due to the chemical complexity and instability with respect to degradation processes. Among natural products, proteins have been largely used in the past as binders but also as adhesives or additives in coating layers. Nevertheless, biological identification of proteins in art-historical objects is one of the most recent achievements obtained in heritage science thanks to the development of specifically tailored bio-analytical strategies. In the context of this active emerging discipline, immunological methods stand out for sensitivity, specificity and versatility for both protein recognition and localization in micro-samples. Furthermore, the growing use of immunological techniques for advanced diagnostics and clinical applications ensures continuous improvement in their analytical performance. Considering such, this review provides an overview of the most recent applications of enzyme linked immunosorbent assay and immunofluorescence microscopy techniques in the field of heritage materials. Specifically, the main strengths and potentials of the two techniques as well as their limits and drawbacks are presented and discussed herein.


Subject(s)
Enzyme-Linked Immunosorbent Assay , Microscopy, Fluorescence , Proteins/analysis , Animals , Caseins/analysis , Humans , Ovalbumin/analysis , Proteins/metabolism
4.
New Microbiol ; 37(2): 237-40, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24858652

ABSTRACT

We describe a case of bloodstream infection caused by a Candida krusei strain that developed echinocandin resistance during caspofungin therapy. Three mutations were found in the HS1 region of the fks1 gene, two of them have never been reported either in C. krusei nor in C. albicans.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Candida/enzymology , Candidiasis/microbiology , Echinocandins/pharmacology , Fungal Proteins/genetics , Fungemia/microbiology , Glucosyltransferases/genetics , Mutation , Aged , Blood/microbiology , Candida/genetics , Humans , Male , Microbial Sensitivity Tests
5.
Med Mycol Case Rep ; 4: 19-22, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24707460

ABSTRACT

Ascending infections of equine uterus frequently result in placentitis and abortions; most of these infections are bacterial and are less commonly due to fungi. This report describes an abortion case in an Arab mare due to Candida guilliermondii that was diagnosed via cytological, histological, cultural and biomolecular assays. The histological lesions found were severe necrotizing placentitis associated with fetal pneumonia. To our knowledge this is the first case of C. guilliermondii abortion reported in equine species.

6.
J Antimicrob Chemother ; 69(4): 1065-74, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24265229

ABSTRACT

OBJECTIVES: Micafungin inhibits 1,3-ß-D-glucan synthase and interferes with fungal cell wall synthesis. Clinically, micafungin has been shown to be efficacious for the treatment of invasive fungal infections. However, little is known about the immunomodulatory activity of micafungin in these infections. METHODS: We evaluated the immunomodulatory activity of escalating doses of micafungin in murine and human polymorphonuclear neutrophils (PMNs) in vitro and in vivo in different preclinical models of invasive aspergillosis, including mice deficient for selected innate immune receptors. RESULTS: Micafungin was able to regulate PMN cytokine response to Aspergillus fumigatus conidia by decreasing the expression of tumour necrosis factor-α and increasing that of interleukin-10 (IL-10). In vivo, the therapeutic efficacy of micafungin was strictly dose-dependent, with the maximum activity observed at the highest dose, concomitant with reduced inflammatory pathology. The anti-inflammatory activity of micafungin required IL-10 and occurred through signalling via the TLR2/dectin-1 and TLR3/TRIF pathways. CONCLUSION: Together, these findings suggest that the therapeutic efficacy of micafungin in aspergillosis is orchestrated by the activation of innate immune receptors affecting the inflammatory/anti-inflammatory balance during infection.


Subject(s)
Aspergillosis/drug therapy , Aspergillus fumigatus/drug effects , Echinocandins/therapeutic use , Immunologic Factors/therapeutic use , Lipopeptides/therapeutic use , Animals , Aspergillosis/microbiology , Bacterial Load , Cells, Cultured , Echinocandins/pharmacology , Female , Histocytochemistry , Humans , Immunologic Factors/pharmacology , Lipopeptides/pharmacology , Lung/microbiology , Lung/pathology , Micafungin , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neutrophils/drug effects , Neutrophils/microbiology , Treatment Outcome
7.
PLoS Pathog ; 9(7): e1003486, 2013.
Article in English | MEDLINE | ID: mdl-23853597

ABSTRACT

The ability to tolerate Candida albicans, a human commensal of the gastrointestinal tract and vagina, implicates that host defense mechanisms of resistance and tolerance cooperate to limit fungal burden and inflammation at the different body sites. We evaluated resistance and tolerance to the fungus in experimental and human vulvovaginal candidiasis (VVC) as well as in recurrent VVC (RVVC). Resistance and tolerance mechanisms were both activated in murine VVC, involving IL-22 and IL-10-producing regulatory T cells, respectively, with a major contribution by the enzyme indoleamine 2,3-dioxygenase 1 (IDO1). IDO1 was responsible for the production of tolerogenic kynurenines, such that replacement therapy with kynurenines restored immunoprotection to VVC. In humans, two functional genetic variants in IL22 and IDO1 genes were found to be associated with heightened resistance to RVVC, and they correlated with increased local expression of IL-22, IDO1 and kynurenines. Thus, IL-22 and IDO1 are crucial in balancing resistance with tolerance to Candida, their deficiencies are risk factors for RVVC, and targeting tolerance via therapeutic kynurenines may benefit patients with RVVC.


Subject(s)
Candida albicans/immunology , Candidiasis, Vulvovaginal/immunology , Immune Tolerance , Immunity, Mucosal , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Interleukins/biosynthesis , T-Lymphocytes, Regulatory/immunology , Animals , Candida albicans/drug effects , Candida albicans/isolation & purification , Candidiasis, Vulvovaginal/genetics , Candidiasis, Vulvovaginal/metabolism , Candidiasis, Vulvovaginal/microbiology , Female , Genetic Association Studies , Genetic Variation , Humans , Immune Tolerance/drug effects , Immunity, Mucosal/drug effects , Immunologic Factors/metabolism , Immunologic Factors/therapeutic use , Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics , Interleukin-10/biosynthesis , Interleukins/genetics , Kynurenine/metabolism , Kynurenine/therapeutic use , Mice , Mice, Inbred C57BL , Mice, SCID , Recurrence , Severe Combined Immunodeficiency/drug therapy , Severe Combined Immunodeficiency/immunology , Severe Combined Immunodeficiency/physiopathology , Specific Pathogen-Free Organisms , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/metabolism , Interleukin-22
8.
Med Mycol ; 51(4): 438-43, 2013 May.
Article in English | MEDLINE | ID: mdl-23170963

ABSTRACT

A yeast strain was isolated from the sputum sample of a leukaemia patient in the Spirito Santo Hospital of Pescara, Italy. The fungus produced a pigment that formed a reddish halo around colonies, and was identified and deposited as a Metschnikowia spp. (accession number IHEM 25107-GenBank accession number JQ921016) in the BCCM/IHEM collection of biomedical fungi and yeasts (Bruxelles, Belgium). Although the physiology of the strain was close to that of Metschnikowia sinensis, the D1/D2 sequence did not correspond to any previously described Metschnikowia species. Phylogeny of the genus Metschnikowia is complex and requires far more analysis. We present the first non-M. pulcherrima Metschnikowia spp. isolate recovered from a human, and emphasize the role of man as a transient carrier of environmental yeasts, the pathogenicity of which still needs to be defined.


Subject(s)
Antifungal Agents/pharmacology , Leukemia/complications , Metschnikowia/isolation & purification , Mycoses/microbiology , Pyrazines/metabolism , Amphotericin B/pharmacology , Base Sequence , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Fluconazole/pharmacology , Humans , Italy , Male , Metschnikowia/classification , Metschnikowia/drug effects , Metschnikowia/physiology , Microbial Sensitivity Tests , Molecular Sequence Data , Mycoses/complications , Phylogeny , Pigments, Biological/metabolism , Sequence Analysis, DNA , Sputum/microbiology , Voriconazole/pharmacology
9.
Antimicrob Agents Chemother ; 56(8): 4268-76, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22644025

ABSTRACT

This study investigated the possible mechanisms underlying the paradoxical caspofungin activity in vivo in preclinical aspergillosis. We evaluated the activity of escalating doses of caspofungin in vivo in different preclinical models of invasive aspergillosis, including mice deficient for selected innate immune receptors. The therapeutic efficacy of caspofungin in experimental invasive aspergillosis was strictly dose dependent, being observed at doses of 0.1 and 1 mg/kg of body weight depending on the experimental models. Paradoxical increase in pulmonary fungal burden as well as inflammatory pathology was observed at the highest dose of caspofungin (5 mg/kg), occurred independently of the so-called Eagle effect and susceptibility to caspofungin in vitro, and was contingent upon the presence of TLR2, Dectin-1, and TLR9. Increased expression of Dectin-1 and TLR9 were observed upon exposure to caspofungin in vitro and in vivo. Together, these findings suggest that the net activity of caspofungin in vivo is orchestrated by the activation, directly or indirectly, of multiple innate immune receptors.


Subject(s)
Antifungal Agents/pharmacology , Aspergillosis/drug therapy , Echinocandins/pharmacology , Lectins, C-Type/metabolism , Lung Diseases, Fungal/drug therapy , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 9/metabolism , Animals , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Aspergillosis/immunology , Aspergillosis/microbiology , Aspergillus fumigatus/drug effects , Caspofungin , Echinocandins/administration & dosage , Echinocandins/therapeutic use , Female , Humans , Lipopeptides , Lung/microbiology , Lung Diseases, Fungal/immunology , Lung Diseases, Fungal/microbiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Microbial Sensitivity Tests , Receptors, Immunologic/metabolism
10.
PLoS One ; 6(11): e28256, 2011.
Article in English | MEDLINE | ID: mdl-22132241

ABSTRACT

In humans, allelic variants in Toll-like receptors (TLRs) associate with several pathologies. However, the underlying cellular and molecular mechanisms of this association remain largely unknown. Analysis of the human TLR9 promoter revealed that the C allele of the rs5743836 polymorphism generates several regulatory sites, including an IL-6-responding element. Here, we show that, in mononuclear cells carrying the TC genotype of rs5743836, IL-6 up-regulates TLR9 expression, leading to exacerbated cellular responses to CpG, including IL-6 production and B-cell proliferation. Our study uncovers a role for the rs5743836 polymorphism in B-cell biology with implications on TLR9-mediated diseases and on the therapeutic usage of TLR9 agonists/antagonists.


Subject(s)
Alleles , B-Lymphocytes/cytology , Interleukin-6/genetics , Polymorphism, Single Nucleotide/genetics , Promoter Regions, Genetic/genetics , Toll-Like Receptor 9/genetics , Up-Regulation/genetics , B-Lymphocytes/drug effects , Base Sequence , Cell Proliferation/drug effects , Genotype , Humans , Lymphocyte Activation/drug effects , Models, Biological , Molecular Sequence Data , Oligodeoxyribonucleotides/pharmacology , Transcription, Genetic/drug effects , Up-Regulation/drug effects
11.
Article in English | MEDLINE | ID: mdl-21368010

ABSTRACT

A case of retrobulbar monolateral optic neuritis due to disseminated Cryptococcosis in a 32-year-old man with a new diagnosis of AIDS is described in the era of combination antiretroviral therapy (cART). The patient presented a monolateral rapid visual loss on day 7 of a liposomal amphotericin B treatment. Neuroradiological imaging showed the presence of retrobulbar neuritis. After starting ART and intravenous metilprednisolone 1 g daily for 3 days, we assisted to a progressive improvement of visual acuity. At 3 months of follow-up, complete clinical resolution was obtained. In this case, in the presence of effective antiretroviral and antifungal treatment, a short course of metilprednisolone was a safe therapy.


Subject(s)
Cryptococcosis , Meningitis, Cryptococcal , Antifungal Agents/therapeutic use , Blindness , Humans , Meningitis, Cryptococcal/drug therapy
12.
Blood ; 116(24): 5394-402, 2010 Dec 09.
Article in English | MEDLINE | ID: mdl-20807886

ABSTRACT

The C-type lectin receptor Dectin-1 plays a pivotal role in antifungal immunity. In this study, the recently characterized human DECTIN1 Y238X early stop codon polymorphism leading to diminished Dectin-1 receptor activity was studied in relation to invasive aspergillosis susceptibility and severity in patients receiving hematopoietic stem cell transplantation. We found that the presence of the DECTIN1 Y238X polymorphism in either donors or recipients of hematopoietic stem cell transplantation increased susceptibility to aspergillosis, with the risk being highest when the polymorphism was present simultaneously in both donors and recipients (adjusted hazard ratio = 3.9; P = .005). Functionally, the Y238X polymorphism impaired the production of interferon-γ and interleukin-10 (IL-10), in addition to IL-1ß, IL-6, and IL-17A, by human peripheral mononuclear cells and Dectin-1 on human epithelial cells contributed to fungal recognition. Mechanistically, studies on preclinical models of infection in intact or bone marrow-transplanted Dectin-1 knockout mice revealed that protection from infection requires a distinct, yet complementary, role of both donor and recipient Dectin-1. This study discloses Dectin-1 deficiency as a novel susceptibility factor for aspergillosis in high-risk patients and identifies a previously unsuspected role for Dectin-1 in antifungal immunity that is the ability to control both resistance and tolerance to the fungus contingent on hematopoietic/nonhematopoietic compartmentalization.


Subject(s)
Aspergillosis/etiology , Disease Susceptibility/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Membrane Proteins/genetics , Membrane Proteins/immunology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/immunology , Polymorphism, Genetic/immunology , Adolescent , Adult , Aged , Animals , Aspergillosis/genetics , Aspergillosis/immunology , Child , Cytokines/biosynthesis , Epithelial Cells/immunology , Epithelial Cells/metabolism , Female , Fungi/immunology , Humans , Lectins, C-Type , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Membrane Proteins/deficiency , Mice , Mice, Knockout , Middle Aged , Nerve Tissue Proteins/deficiency , Young Adult
13.
Acc Chem Res ; 43(6): 867-76, 2010 Jun 15.
Article in English | MEDLINE | ID: mdl-20438070

ABSTRACT

Diagnostic immunology is a powerful tool, widely used in clinical and biochemical laboratories for detecting molecules. In recent years, the technique has been adapted to materials sciences as a result of the extensive advances achieved in immunology. Today, many companies supply custom antibodies as well as new high-performance bioprobes for virtually any use. The idea of using immunodetection in the field of conservation science is not new. This analytical methodology is, in fact, particularly attractive for investigating biopolymers in painting materials; it is highly sensitive and selective with respect to the biological source of the target molecules. Among biopolymers, proteins have been widely used in the past as painting binders, adhesives, and additives in coating layers. An accurate assessment of these materials is necessary to obtain deeper insights into an artist's technique as well as to design proper restoration and conservation methods. In spite of the diagnostic potential offered by immunodetection-based techniques, some analytical drawbacks had, until recently, limited their use in routine applications in conservation science. In this Account, we highlight the most important results achieved in our research on the development of analytical methodologies based on the use of enzyme-linked immunosorbent assay (ELISA) and immuno-fluorescence microscopy (IFM) techniques for the highly sensitive and specific identification of proteins in artistic and archeological materials. ELISA and IFM offer two alternative analytical routes to this final goal: ELISA provides a fast, cost-effective, quantitative analysis of microsamples put in solution, whereas IFM combines the immunodetection of the targeted molecules with the characterization of their spatial distribution. The latter approach is of great value in the stratigraphic investigation of paintings. We discuss the limits and strengths of these methodologies in the context of the complex matrixes usually found in the investigated materials and the prolonged aging that they have undergone. Immunology is a relatively new technique in conservation science, providing a rich new field for innovation. We see two areas that are particularly ripe for future contributions. The commercial manufacture of antibodies specifically tailored for use in cultural heritage studies holds enormous potential. Moreover, the need for further refinement of detection systems in immuno-fluorescence techniques, especially the suppression of the autofluorescence background in painting materials, offers an abundance of opportunities for researchers. Immunology is a relatively new technique in conservation science, providing a rich new field for innovation.


Subject(s)
Enzyme-Linked Immunosorbent Assay , Microscopy, Fluorescence , Paint , Paintings , Proteins/analysis , Antibodies/immunology , Fluorescent Antibody Technique , Fluorescent Dyes/chemistry , Proteins/chemistry , Proteins/immunology
14.
Int J Infect Dis ; 14(6): e460-8, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19828347

ABSTRACT

Fungi are a major threat in immunocompromised patients. Despite presenting similar degrees of immunosuppression, not all individuals at-risk ultimately develop fungal diseases. The traditional view of immune suppression as a key risk factor for susceptibility to fungal infections needs to be accommodated within new conceptual advances on host immunity and its relationship to fungal disease. The critical role of the immune system emphasizes the contribution of host genetic polymorphisms to fungal disease susceptibility. This review highlights the present knowledge on innate immunity genetics that associates with susceptibility to fungal diseases.


Subject(s)
Genetic Predisposition to Disease , Immunity, Innate/genetics , Mycoses/genetics , Receptors, Pattern Recognition/genetics , Animals , Humans , Polymorphism, Genetic
15.
Exp Hematol ; 37(9): 1022-9, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19539691

ABSTRACT

OBJECTIVE: Discovery of genetic variations in the genes encoding for Toll-like receptors (TLRs) has highlighted a potential link between genomic variation of the host and susceptibility to infections. MATERIALS AND METHODS: We investigated the association between polymorphisms in the TLR2, TLR4, and TLR9 genes in recipients of allogeneic hematopoietic stem cell transplant and susceptibility to infections caused by cytomegalovirus and filamentous fungi. RESULTS: A significant association was observed between the presence of the T-1237C polymorphism (TLR9) and susceptibility to viral pneumonia (p=0.04; odds ratio [OR]: 1.73). For fungi, a significant association was observed between the presence of the cosegregating Asp299Gly/Thr399Ile polymorphisms (TLR4) and fungal colonization (p=0.003; OR: 10.6). However, susceptibility to fungal infections, predominantly fungal pneumonia, was instead significantly decreased in the presence of the same polymorphisms (p=0.03; OR: 0.23). CONCLUSION: Thus, fungal colonization may not predict susceptibility to infection in the presence of these single nucleotide polymorphisms. The finding that defective viral but not fungal sensing may predict susceptibility to infection highlights the divergent function of TLRs in the pathogenesis of opportunistic infections.


Subject(s)
Cytomegalovirus Infections/genetics , Genetic Predisposition to Disease , Infections/genetics , Mycoses/genetics , Polymorphism, Single Nucleotide , Stem Cell Transplantation , Toll-Like Receptor 4/genetics , Toll-Like Receptor 9/genetics , Adult , Cytomegalovirus/immunology , Cytomegalovirus Infections/immunology , Female , Hematologic Neoplasms/genetics , Hematologic Neoplasms/immunology , Hematologic Neoplasms/microbiology , Hematologic Neoplasms/therapy , Hematologic Neoplasms/virology , Humans , Infections/immunology , Male , Middle Aged , Mycoses/immunology , Retrospective Studies , Toll-Like Receptor 2/genetics , Toll-Like Receptor 2/immunology , Toll-Like Receptor 4/immunology , Toll-Like Receptor 9/immunology , Transplantation, Homologous
17.
Int Immunol ; 19(11): 1261-70, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17804687

ABSTRACT

Reactivation of latent human cytomegalovirus following allogeneic transplantation is a major cause of morbidity and mortality and predisposes to severe complications. Thymosin alpha1 (Talpha1), a naturally occurring thymic peptide, is approved for treatment of some viral infections and as an immune adjuvant. Talpha1 successfully primed dendritic cells (DCs) for anti-microbial T helper type 1 resistance through Toll-like receptor (TLR) 9 signaling. We sought to determine here whether Talpha1 could play a role in murine cytomegalovirus infection (MCMV). To this purpose, susceptible, resistant and TLR-deficient mice were infected with MCMV, treated with Talpha1 and assessed for protection in term of microbiological and immunological parameters. Talpha1 protected susceptible and resistant mice from MCMV infection. The anti-viral effect of Talpha1 occurred through the activation of plasmacytoid DCs via the TLR9/myeloid differentiation primary response gene 88-dependent viral recognition sensing, leading to the activation of IFN regulatory factor 7 and the promotion of the IFN-alpha/IFN-gamma-dependent effector pathway.


Subject(s)
Dendritic Cells/immunology , Herpesviridae Infections/immunology , Thymosin/analogs & derivatives , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Dendritic Cells/cytology , Dendritic Cells/metabolism , Herpesviridae Infections/virology , Interferon Regulatory Factor-7/immunology , Interferon Regulatory Factor-7/metabolism , Interferons/immunology , Interferons/metabolism , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Mutant Strains , Muromegalovirus/immunology , Myeloid Differentiation Factor 88/immunology , Myeloid Differentiation Factor 88/metabolism , Thymalfasin , Thymosin/immunology , Thymosin/metabolism , Toll-Like Receptor 9/immunology , Toll-Like Receptor 9/metabolism
18.
Blood ; 108(10): 3387-96, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-16840729

ABSTRACT

Reactivation of latent human cytomegalovirus (HCMV) following allogeneic transplantation is a major cause of morbidity and mortality and predisposes to severe complications, including superinfection by Aspergillus species (spp). Antimicrobial polypeptides, including defensins and mannan-binding lectin, are known to block viral fusion by cross-linking sugars on cell surface. Pentraxin 3 (PTX3), a member of the long pentraxin family, successfully restored antifungal immunity in experimental hematopoietic transplantation. We assessed here whether PTX3 binds HCMV and murine virus (MCMV) and the impact on viral infectivity and superinfection in vivo. We found that PTX3 bound both viruses, reduced viral entry and infectivity in vitro, and protected from MCMV primary infection and reactivation as well as Aspergillus superinfection. This occurred through the activation of interferon (IFN) regulatory factor 3 (IRF3) in dendritic cells via the TLR9/MyD88-independent viral recognition sensing and the promotion of the interleukin-12 (IL-12)/IFN-gamma-dependent effector pathway.


Subject(s)
C-Reactive Protein/physiology , Herpesviridae Infections , Interferon Regulatory Factor-3/metabolism , Muromegalovirus/pathogenicity , Nerve Tissue Proteins/physiology , Toll-Like Receptor 9/metabolism , Virus Activation , Animals , C-Reactive Protein/immunology , Cytomegalovirus/metabolism , Cytomegalovirus/pathogenicity , Dendritic Cells , Interferon-gamma , Interleukin-12 , Mice , Mice, Knockout , Muromegalovirus/metabolism , Myeloid Differentiation Factor 88 , Nerve Tissue Proteins/immunology , Serum Amyloid P-Component/immunology , Serum Amyloid P-Component/physiology , Signal Transduction
19.
J Immunol ; 176(3): 1712-23, 2006 Feb 01.
Article in English | MEDLINE | ID: mdl-16424201

ABSTRACT

The inherent resistance to diseases caused by Aspergillus fumigatus suggests the occurrence of regulatory mechanisms that provide the host with adequate defense without necessarily eliminating the fungus or causing unacceptable levels of host damage. In this study, we show that a division of labor occurs between functionally distinct regulatory T cells (Treg) that are coordinately activated by a CD28/B-7-dependent costimulatory pathway after exposure of mice to Aspergillus conidia. Early in infection, inflammation is controlled by the expansion, activation and local recruitment of CD4+CD25+ Treg capable of suppressing neutrophils through the combined actions of IL-10 and CTLA-4 on indoleamine 2,3-dioxygenase. The levels of IFN-gamma produced in this early phase set the subsequent adaptive stage by conditioning the indoleamine 2,3-dioxygenase-dependent tolerogenic program of dendritic cells and the subsequent activation and expansion of tolerogenic Treg, which produce IL-10 and TGF-beta, inhibit Th2 cells, and prevent allergy to the fungus. The coordinate activation of Treg may, however, be subverted by the fungus, as germinating conidia are capable of interfering with anti-inflammatory and tolerogenic Treg programs. Thus, regulation is an essential component of the host response in infection and allergy to the fungus, and its manipulation may allow the pathogen to overcome host resistance and promote disease.


Subject(s)
Aspergillus fumigatus/immunology , Immune Tolerance/physiology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Tryptophan/metabolism , Animals , Aspergillosis/enzymology , Aspergillosis/immunology , Aspergillosis/metabolism , B7-1 Antigen/genetics , B7-2 Antigen/genetics , CD28 Antigens/genetics , Cells, Cultured , Coculture Techniques , Disease Susceptibility , Female , Hypersensitivity/immunology , Immunity, Cellular , Immunity, Innate , Indoleamine-Pyrrole 2,3,-Dioxygenase/physiology , Mice , Mice, Inbred BALB C , Mice, Knockout , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/microbiology , T-Lymphocytes, Regulatory/microbiology
20.
Novartis Found Symp ; 279: 66-77; discussion 77-9, 216-9, 2006.
Article in English | MEDLINE | ID: mdl-17278386

ABSTRACT

The inherent resistance to diseases caused by Aspergillus fumigatus suggests the occurrence of regulatory mechanisms that provide the host with adequate defence without necessarily eliminating the fungus or causing unacceptable levels of host damage. Efficient responses to the fungus require different mechanisms of immunity. Dendritic cells (DCs) are uniquely able to decode the fungus-associated information and translate it into qualitatively different T helper (Th) and regulatory (Treg) cell responses. A division of labour occurred between functionally distinct Treg that were coordinately activated by a CD28/B.7-dependent costimulatory pathway after exposure of mice to Aspergillus conidia. Early in infection, inflammation was controlled by the expansion, activation and local recruitment of CD4+CD25+ Treg capable of suppressing neutrophils through the combined actions of interleukin (IL10) and cytotoxic T lymphocyte antigen 4 (CTLA4) on indoleamine 2,3-dioxygenase (IDO). The levels of IFNgamma produced in this early phase set the subsequent adaptive stage by conditioning the IDO-dependent tolerogenic program of DCs and the subsequent activation and expansion of tolerogenic Treg, which produced IL10 and transforming growth factor (TGF)beta, inhibited Th2 cells, and prevented allergy to the fungus. Thus, regulation is an essential component of the host response in infection and allergy to the fungus, and its manipulation may allow the pathogen to overcome host resistance and promote disease.


Subject(s)
Aspergillus fumigatus/immunology , Immune Tolerance/immunology , Animals , Aspergillus fumigatus/ultrastructure , Dendritic Cells/ultrastructure , Humans , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/microbiology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...